Drug Profile
GSK 971086
Alternative Names: 971086; GSK971086Latest Information Update: 01 Aug 2023
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class
- Mechanism of Action Androgen receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Sarcopenia
Most Recent Events
- 29 Apr 2011 No development reported - Phase-I for Sarcopenia in USA (unspecified route)